Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +335.41%
#4 aPriori aPriori +160.22%
#5 Bedrock Bedrock +74.34%
#6 Cysic Cysic +50.91%
#7 Prom Prom +46.77%
#8 Playnance Playnance +34.90%
#9 Bitway Bitway +28.95%
#10 COTI COTI +25.85%
Coin of the day
Wrapped One Wrapped One
設定
言語
日本
通貨
USD
テーマ
Cotinga Pharmaceuticals Inc. Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Inc.

COTQF
株式のランク #42319
Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused... Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative treatments for cancer and other medical conditions currently lacking adequate solutions. Its leading therapeutic asset is COTI-2, an oral small molecule formulated to target the p53 tumor suppressor gene. The company is also progressing COTI-219, another oral small molecule compound, specifically engineered to inhibit mutant forms of KRAS without affecting the normal functions of the KRAS gene. In collaboration with St. Vincent's University Hospital, Cotinga is conducting research to evaluate COTI-2 when combined with eribulin for patients suffering from triple-negative metastatic breast cancer. The company, which was previously known as Critical Outcome Technologies Inc., rebranded to Cotinga Pharmaceuticals Inc. in January 2018. Its corporate base is situated in Toronto, Canada.
株価
$0.0001
最終同期: 2026-07-02
時価総額
$2.20K
変化（1日）
0.00%
変化（1年）
0.00%
国
CA
取引 Cotinga Pharmaceuticals Inc. (COTQF)

カテゴリー

Healthcare
Cotinga Pharmaceuticals Inc.（COTQF）の株式分割履歴
Cotinga Pharmaceuticals Inc.株（シンボル：COTQF）は合計で0回の株式分割を実施しました。
最新の株式分割はAug 12, 2026に行われました。
Aug 12, 2026より前に購入されたCOTQF株は、現在0COTQF株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR